The Relative Strength (RS) Rating for Agilent Technologies entered a new percentile Tuesday, as it got a lift from 70 to 73.
This unique rating measures market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks compares to the rest of the market.
History shows that the best stocks typically have an RS Rating north of 80 in the early stages of their moves. See if Agilent Technologies can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Agilent Technologies is now considered extended and out of buy range after clearing a 143.07 buy point in a first-stage double bottom. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings grew 6% last quarter, up from -8% in the prior report. Revenue also increased, from -6% to 1%.
The company holds the No. 4 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte is the top-ranked stock within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
